PULMONX CORPORATION Operating Lease Cost
PULMONX CORPORATION (LUNG) reported Operating Lease Cost of $1.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-04
- PULMONX CORPORATION operating lease, cost for the quarter ending 2026-06-30 was $830.00K, a 2.01% decline year-over-year.
- PULMONX CORPORATION operating lease, cost for the quarter ending 2026-03-31 was $837.00K, a 3.59% increase year-over-year.
- PULMONX CORPORATION operating lease, cost for the quarter ending 2025-12-31 was $827.00K, a 4.03% increase year-over-year.
- PULMONX CORPORATION operating lease, cost for the quarter ending 2025-09-30 was $809.00K, a 3.98% increase year-over-year.
- PULMONX CORPORATION operating lease, cost for fiscal 2025 was $3.29M, a 5.79% increase from fiscal 2024.
- PULMONX CORPORATION operating lease, cost for fiscal 2024 was $3.11M, a 7.87% increase from fiscal 2023.
- PULMONX CORPORATION operating lease, cost for fiscal 2023 was $2.88M, a 0.31% decline from fiscal 2022.
- PULMONX CORPORATION operating lease, cost for fiscal 2022 was $2.89M, a 0.52% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $830.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.67M 10-Q · filed 2026-08-04 | $2.49M derived: sum of 3 quarters · filed 2026-08-04 | $3.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $837.00K 10-Q · filed 2026-05-04 | $1.66M derived: sum of 2 quarters · filed 2026-05-04 | $2.47M derived: sum of 3 quarters · filed 2026-05-04 | $3.32M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $827.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.64M derived: sum of 2 quarters · filed 2026-03-10 | $2.48M derived: sum of 3 quarters · filed 2026-08-04 | $3.29M 10-K · filed 2026-03-10 |
| 2025-09-30 | $809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.66M derived: sum of 2 quarters · filed 2026-08-04 | $2.46M 10-Q · filed 2025-11-12 | $3.26M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.66M 10-Q · filed 2026-08-04 | $2.45M derived: sum of 3 quarters · filed 2026-08-04 | $3.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $808.00K 10-Q · filed 2026-05-04 | $1.60M derived: sum of 2 quarters · filed 2026-05-04 | $2.38M derived: sum of 3 quarters · filed 2026-05-04 | $3.20M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.57M derived: sum of 2 quarters · filed 2026-03-10 | $2.39M derived: sum of 3 quarters · filed 2026-03-10 | $3.11M 10-K · filed 2026-03-10 |
| 2024-09-30 | $778.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.59M derived: sum of 2 quarters · filed 2025-11-12 | $2.32M 10-Q · filed 2025-11-12 | $3.04M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $816.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.54M 10-Q · filed 2025-08-01 | $2.26M derived: sum of 3 quarters · filed 2025-08-01 | $2.98M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $722.00K 10-Q · filed 2025-05-02 | $1.44M derived: sum of 2 quarters · filed 2025-05-02 | $2.16M derived: sum of 3 quarters · filed 2025-05-02 | $2.88M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $721.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.44M derived: sum of 2 quarters · filed 2025-02-25 | $2.16M derived: sum of 3 quarters · filed 2025-02-25 | $2.88M 10-K · filed 2025-02-25 |
| 2023-09-30 | $721.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $1.44M derived: sum of 2 quarters · filed 2024-11-01 | $2.16M 10-Q · filed 2024-11-01 | $2.89M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $721.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.44M 10-Q · filed 2024-08-02 | $2.17M derived: sum of 3 quarters · filed 2024-08-02 | $2.89M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $721.00K 10-Q · filed 2024-05-03 | $1.44M derived: sum of 2 quarters · filed 2024-05-03 | $2.17M derived: sum of 3 quarters · filed 2024-05-03 | $2.89M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $723.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.45M derived: sum of 2 quarters · filed 2024-02-27 | $2.17M derived: sum of 3 quarters · filed 2024-02-27 | $2.89M 10-K · filed 2024-02-27 |
| 2022-09-30 | $724.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.45M derived: sum of 2 quarters · filed 2023-11-03 | $2.17M 10-Q · filed 2023-11-03 | $2.93M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.45M 10-Q · filed 2023-08-04 | $2.21M derived: sum of 3 quarters · filed 2023-08-04 | $2.87M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $724.00K 10-Q · filed 2023-05-08 | $1.49M derived: sum of 2 quarters · filed 2023-05-08 | $2.15M derived: sum of 3 quarters · filed 2023-05-08 | $2.87M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $761.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.43M derived: sum of 2 quarters · filed 2023-03-01 | $2.15M derived: sum of 3 quarters · filed 2023-03-01 | $2.88M 10-K · filed 2023-03-01 |
| 2021-09-30 | $665.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.39M derived: sum of 2 quarters · filed 2022-11-08 | $2.12M 10-Q · filed 2022-11-08 | $2.87M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $724.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.45M 10-Q · filed 2022-08-08 | $2.21M derived: sum of 3 quarters · filed 2022-08-08 | $2.73M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $728.00K 10-Q · filed 2022-05-09 | $1.48M derived: sum of 2 quarters · filed 2022-05-09 | $2.00M derived: sum of 3 quarters · filed 2022-05-09 | $2.43M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.28M derived: sum of 2 quarters · filed 2022-03-01 | $1.70M derived: sum of 3 quarters · filed 2022-03-01 | $2.08M 10-K · filed 2022-03-01 |
| 2020-09-30 | $520.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $942.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.32M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $422.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $802.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $380.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $1.04M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |